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RA is a chronic, joint-centered autoimmune disorder characterized 
by inflammation and proliferation of synovium, accompanied by 
erosion of underlying cartilage and bone. Although the factors ini-
tiating this disease are not fully understood, its progression can be 
largely attributed to the activation of lymphocyte and osteoclast 
(OC) lineages (1). Other forms of inflammatory arthritis, such as 
that accompanying psoriasis, have similar pathogenesis (2, 3).
Early in the course of RA, T cells localize to the synovium, where 
they interact with resident macrophage-like type A synoviocytes 
(4). In established RA, T cells represent the most abundant inflam-
matory cell in the joint, where they stimulate type A synoviocytes 
to secrete proinflammatory cytokines. In addition, T cells also 
induce B cell maturation, a necessary step in the generation of 
rheumatoid factors, polyclonal antibodies against the Fc domain 
of IgG. Additionally, antibodies with specificity for a variety of for-
eign antigens, as well as autoantigens, can be found in RA synovial 
tissue, where they activate the complement cascade, contributing 
to joint destruction (1). However, no single autoantibody has been 
found in all patients. Susceptibility to RA is also linked to particu-
lar alleles in the major histocompatibility locus, which suggests 
that the context of antigen presentation to lymphocytes is also 
important. Thus, both T and B lymphocyte activation contribute 
to joint inflammation and injury.
Degradation of bone, a major component of the crippling RA 
lesion, can only be accomplished by OCs, which are derived from 
monocytes/macrophages in the pannus (5). The critical media-
tors of osteoclastogenesis, M-CSF and receptor activator of NF-κB 
ligand (RANKL), are expressed by bone marrow stromal cells, 
osteoblast, and activated T cells. Importantly, RANKL expression 
by synovial fibroblastoid cells is enhanced in RA joints (6), as are 
other cytokines that enhance osteoclastogenesis, such as TNF-α. 
Blockade of RANKL blocks bone erosion in models of adjuvant 
arthritis (7) or serum transfer (8). Mice expressing a human TNF-α 
transgene on a c-fos–/– background completely lack functional 
OCs and are fully protected against bone erosion in spite of severe 
inflammatory arthritis (9), which confirms the central role of OCs 
in arthritic osteolysis.
Because the differentiation and function of T and B lymphyo-
cytes and OCs is dependent on NF-κB (10, 11) and because the 
inflammatory milieu induces NF-κB activation in these target cells, 
inhibitors of NF-κB are considered to be of potential therapeutic 
use in the treatment of RA (12). It is now recognized that there are 2 
distinct NF-κB pathways, classical and alternative (13). The classical 
pathway, activated by most NF-κB–inducing cytokines, including 
TNF-α and IL-1, involves degradation of IκBα and release of active 
NF-κB dimers, primarily p65/p50, into the nucleus. The alterna-
tive pathway, activated by a subset of cytokines including CD40L, 
lymphotoxin-β (Lt-β), and RANKL, is controlled by NF-κB–induc-
ing kinase (NIK), which activates IκB kinase α (IKKα), prompting 
generation of the active NF-κB subunit p52 from its precursor 
p100. The alternative pathway is activated in concert with the clas-
sical pathway by these cytokines, and its primary transcriptionally 
active nuclear complex is RelB/p52. Several studies have shown that 
blockade of classical NF-κB signaling, through the use of inhibitors 
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and in knockout mice, reduces both inflammation and bone ero-
sion in murine models of arthritis (14–17). However, because of its 
central role in many normal biological processes, global inhibition 
of classical NF-κB may not be therapeutically viable. The alternative 
NF-κB pathway appears to be activated by a much more restricted 
set of signals and thus might represent a better therapeutic target. 
However, none of the previous studies addresses the possible role 
of this pathway in arthritis.
The role of the NIK/IKKα/p100/p52 pathway in the immune 
system has been established in several model systems. NIK-defi-
cient mice lack peripheral lymph nodes and Peyer’s patches, due 
to defects in the stromal cell response to Lt-β (18–20). In intact 
NIK-deficient animals, this stromal cell abnormality also contrib-
utes to lymphocyte dysfunction, with decreased antibody produc-
tion after immunization (18) and delayed clearance of pathogens 
(21, 22). Bone marrow transplant experiments have demonstrated 
cell-autonomous defects in lymphocytes, including decreased 
proliferation of both B and T cells and reduced antibody produc-
tion, although the degree of dysfunction depends on the mode of 
stimulation and the specific function assayed (23). Studies using 
lymphocytes with defects in the molecules downstream of NIK 
have confirmed the important role of this pathway in B cell matu-
ration (24, 25). The reduced ability of NIK-deficient mice to clear 
pathogens suggests that NIK is also important in T cell function. 
However, the cell-autonomous effect of NIK deficiency in T cells 
has not been explored in disease models.
We have previously shown that Nik–/– mice have normal basal 
bone structure but are resistant to RANKL- or parathyroid hor-
mone–stimulated (PTH-stimulated) osteoclastogenesis (26). 
Additionally, Nik–/– precursors are highly resistant to RANKL-
induced osteoclastogenesis in vitro. Although RANKL-naive 
precursors have intact classical NF-κB signaling, treatment with 
RANKL induces accumulation of the IκB-like p100 protein, which 
leads to inhibition of both the classical and alternative pathways. 
Recently it has been shown that IKKα–/– mice have a similar OC 
defect (27). In contrast, Nfkb1–/–Nfkb2–/– mice, which lack both 
the p50 and p52 NF-κB subunits, are osteopetrotic and have no 
OCs, presumably due to an earlier and more profound blockade 
in global NF-κB signaling (11, 28).
In this article, we examine the importance of NIK in the peri-
articular bone erosion that accompanies inflammatory arthritis 
using the lymphocyte-independent serum transfer model (29). 
Additionally, we explore the role of NIK in the induction of 
inflammatory arthritis using 2 models dependent on lymphocyte 
function, antigen-induced arthritis (AIA) (30) and the spontane-
ous K/BxN (KRN × NOD) model (31). We find that NIK is critical 
for both the induction of inflammation by lymphocytes and for 
bone erosion by OCs.
Results
Role of NIK in bone erosion. Having previously shown that Nik–/– mice 
are resistant to induction of osteoclastogenesis by RANKL and 
PTH in vivo (26), we set out to determine whether this would hold 
true in a model of human disease such as RA. We chose a variant 
of the well-described serum transfer model in which serum from 
K/BxN mice is injected into naive recipients. K/BxN mice expe-
rience a spontaneous autoimmune arthritis mediated by T cell 
and B cell interactions resulting in the production of pathogenic 
anti–glucose-6-phosphate isomerase antibodies (32). Transfer 
of serum, which contains antibodies and TNF-α, from arthritic 
K/BxN mice results in the rapid development in recipients of joint 
inflammation resembling the spontaneous K/BxN arthritis both 
clinically and histologically (29). However, this serum transfer 
arthritis (STA) is mediated primarily by neutrophils and comple-
ment and does not require T cells and B cells in the recipient (29, 
33). Thus, using STA, we could examine the role of NIK in bone 
erosion separate from its role in lymphocytes. Although STA can 
be induced in a wide variety of mouse strains, there is significant 
variability in the intensity of inflammation only (34). Our colony 
of Nik?/? mice is on the 129Sv/Ev background, which is relatively 
resistant to STA, with only minimal inflammation induced in 
Nik+/+ mice following a single injection of serum (data not shown). 
Therefore, Nik+/+ and Nik–/– mice were injected with K/BxN serum 
on days 0, 2, and 7. Additionally, LPS was administered on day 2. 
The clinical score and thickness of hind paws of Nik–/– mice are 
very similar to those of Nik+/+ mice through day 14, with no statis-
tically significant differences (P < 0.05) at any time point (Figure 1, 
A and B). These clinical data suggest that NIK is not important for 
the inflammatory response in STA.
In the setting of inflammatory arthritis, osteoclastogenesis and 
bone erosion are induced by the production of RANKL and TNF-α 
by inflammatory and synovial cells. We therefore investigated 
the induction of these cytokines in the ankle joints of mice in the 
early phases of STA by semiquantitative RT-PCR. In both Nik+/+ 
Figure 1
Equivalent inflammatory response to serum transfer arthritis. Response of Nik+/+ and Nik–/– mice to arthritogenic serum was evaluated from days 
0 to 14 by clinical scoring (A) and measurement of hind paw thickness (B). Clinical scores were obtained by observation of all 4 paws, with a 
maximum score of 4 indicating whole-paw redness and swelling in all 4. Hind paw thickness was measured by digital gauge at the ankle, and 
the sum of the data for both paws was plotted. Graphs show mean ± SEM at each data point for 8 mice. There were no significant differences 
(P < 0.05) in either parameter between Nik+/+ and Nik–/– mice. (C) Semiquantitative RT-PCR analysis of RNA derived from hind paws at days 0, 
3, and 4 shows that RANKL and TNF-α are both induced by injection of arthritogenic serum in Nik+/+ and Nik–/– animals.
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and Nik–/– mice, RANKL and TNF-α messages were substantially 
increased above baseline (Figure 1C). This finding is in agreement 
with a previous study that was unable to demonstrate a role for 
NIK in TNF-α production in the context of human RA (35).
Histological sections of hind paws were stained with H&E and 
tartrate resistant acid phosphatase (TRAP), a marker of OC dif-
ferentiation. In control mice, not injected with serum, the talus, 
calcaneus, and metatarsal bones have smooth surfaces and open 
joint spaces free of cells (Figure 2, A and D). OCs are confined to 
marrow spaces (Figure 2G, arrowheads). In Nik+/+ mice (Figure 2, B 
and E), joint spaces are narrowed, filled primarily with neutrophils 
and synoviocytes, and bone contours are irregular, showing pan-
nus invasion as well as new bone formation. 
TRAP stains showed abundant OCs on the 
bone surfaces, especially in areas of pan-
nus invasion (Figure 2H, arrows). Although 
Nik–/– hind paws show a similar degree of 
inflammation and narrowing of joint spaces 
(Figure 2, C and F), only rare OCs are seen 
on largely smooth bone surfaces (Figure 2I, 
arrows). New bone formation, particularly 
on the dorsal tibia and plantar calcaneus, 
was similar in Nik+/+ and Nik–/– mice (Fig-
ure 2, B and C, asterisk). Slides of the more 
inflamed hind paw of each animal were 
scored for inflammation and bone erosion, 
using an arbitrary scale (see Methods), by a 
blinded observer. While there was no differ-
ence in inflammation between the 2 groups, 
Nik–/– paws showed significantly less bone 
erosion (Figure 2J). Additionally, the number 
of TRAP+ OCs on the bone surface, as well 
as adjacent to marrow spaces, was quanti-
tated in the region shown in Figure 2, G–I. 
Nik–/– paws had significantly fewer OCs in 
both compartments, with 4.8-fold fewer OCs 
on the surface (Figure 2K). In order to con-
firm this histological evidence of reduced 
bone resorption, we measured TRAP5b lev-
els in the serum prior to, and on day 14 of, 
STA. While Nik+/+ mice showed a significant 
increase in serum TRAP5b levels, Nik–/– mice 
did not (Figure 2L). Thus, although NIK is 
not required for the inflammatory response 
in STA, it is needed for bone erosion.
Previously we showed that isolated Nik–/– 
OC precursors are resistant to RANKL-medi-
ated osteoclastogenesis in vitro (26). Because 
TNF-α synergizes with RANKL to enhance 
osteoclastogenesis in wild-type cells, and 
TNF-α levels are substantially elevated in 
STA (Figure 1C and ref. 15), we examined the 
effects of TNF-α on Nik–/– osteoclastogenesis 
in vitro (Supplemental Figure 2; supplemen-
tal material available online with this article; 
doi:10.1172/JCI23763DS1). In the presence 
of NIK, addition of TNFα with very low lev-
els of RANKL (2.5 ng/ml) yielded confluent 
sheets of TRAP+ OCs. In the absence of NIK, 
only a few mononuclear TRAP+ cells were 
produced. Only very high doses of RANKL (150 ng/ml), which are 
greater than the optimal dose for wild-type osteoclastogenesis, 
were able to synergize with TNF-α to generate some multinucle-
ated, TRAP+ cells in Nik–/– cultures. The relative resistance of Nik–/– 
precursors to RANKL- and TNF-α–induced osteoclastogenesis is 
similar to that of IKKα–/– cells (27).
Role of NIK in inflammation in AIA. Because RA in humans is an 
autoimmune disease mediated by the interactions of lymphocytes 
and APCs, we next sought to determine whether NIK was impor-
tant in the induction of lymphocyte-dependent inflammatory 
arthritis models. AIA is induced by systemic immunization with 
methylated BSA (mBSA), followed by local injection of mBSA into 
Figure 2
Histological evaluation of STA. Hind paws from control mice (A, D, and G) and from Nik+/+ (B, 
E, and H) and Nik–/– (C, F, and I) mice with STA at day 14 were sectioned and stained with 
H&E (A–F) or TRAP (G–I). In control sections (A and D), bones were closely apposed, with 
smooth surfaces and no inflammatory infiltrate. The TRAP stain (G) shows scattered OCs 
(stained red) at bone/marrow interfaces (arrowheads) but none on bone surfaces. In contrast, 
Nik+/+ paws from serum-injected mice (B and E) had an extensive inflammatory infiltrate in 
the joint spaces. In the TRAP stain (H), OCs were prominent in marrow (arrowheads) and on 
bone surfaces (arrows), particularly where the inflammatory pannus was adjacent. In these 
areas, the bone surface was irregular, which indicates bone erosion. Nik–/– mice with arthritis 
(C and F) show an inflammatory infiltrate similar to that of Nik+/+ mice. However, bone con-
tours remain smooth. The TRAP stain (I) shows OCs within the marrow (arrowhead) but few 
on bone surfaces, even where adjacent to pannus (arrow). Scale bar: 500 µm for A–C; 200 
µm for D–F; and 100 µm for G–I. (J) Histological sections were scored for inflammation (left) 
based on H&E stains and for bone erosion (right) based on TRAP stains according to an 
arbitrary scale of 0–3. (K) TRAP-stained sections were evaluated by histomorphometry in the 
regions shown in H–I. The mean number of OCs per mm (± SD) present on the bone surface 
(left) and at the marrow interface (right) is shown. (*P < 0.01; **P < 0.00005, Nik–/– compared 
with Nik+/+; n = 7–8 per group). (L) Serum levels of TRAP5b, a form of the enzyme specific 
for active OCs, were determined 1 day prior to first serum injection (pre) and at day 14 (STA). 
*P < 0.01 compared with pre-injection Nik+/+ by paired Student’s t test; n = 4)
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a single joint space. Induction of AIA is dependent on T lympho-
cyte function (30), and, in contrast to collagen-induced arthritis, 
it can be induced in a variety of mouse strains.
Nik+/– (n = 7) and Nik–/– (n = 9) mice were immunized with mBSA 
and with adjuvant and pertussis toxin on days 0 and 7 and were 
injected with mBSA directly into the right knee joint space on day 
21. As a control, left knees were injected with PBS only. All but 1 
Nik+/– mouse had severe arthritis on day 32, while none of the Nik–/– 
mice showed severe inflammation (Table 1 and Figure 3, A–C). This 
indicates that NIK is essential for the induction of AIA.
NIK is required for the development of lymph node stromal cells, 
and in its absence there are no peripheral lymph nodes. To determine 
whether lymph nodes, as a site of antigen presentation, are needed 
for the induction of AIA, we studied the lymphotoxin α–/– (LT-α–/–) 
mouse. LT-α–/– mice also lack peripheral lymph nodes, but their lym-
phocyte function is intact (36, 37). With the same induction pro-
tocol used for Nik+/– and Nik–/– mice, 3 of 4 LT-α–/– mice had severe 
AIA, while the fourth had mild arthritis (Table 1 and Figure 3D). 
Therefore, the presence of lymph nodes is not required for AIA.
Next, to determine whether Nik–/– lymphocytes could mediate 
AIA in the presence of an intact lymph node stroma, we utilized 
the AIA model in the context of lymphocyte transfer. Rag2–/– mice 
have no mature T or B lymphocytes but an intact lymph node 
stroma, and they are available on the same 129Sv/Ev strain as the 
NIK mice. Therefore, wild-type lymphocytes do not cause a graft-
versus-host reaction in a nonirradiated Rag2–/– recipient (38). One 
day prior to the first mBSA immunization, at day 1, we injected a 
suspension of either Nik+/+ or Nik–/– splenocytes into each Rag2–/– 
recipient without previous irradiation. The subsequent regimen 
for induction of AIA was the same as before. Nine of 12 Rag2–/– 
recipients of Nik+/+ splenocytes showed severe knee joint inflam-
mation on day 32, compared with 0 of 8 recipients of Nik–/– cells 
(P < 0.0001; Table 1 and Figure 3, E and F). To ensure that Nik–/– 
lymphocytes had survived for the duration of the experiment as 
well as Nik+/+ cells, we performed flow cytometry for the T cell 
markers CD90 on splenocytes at the time of sacrifice (day 32). The 
number of T cells was comparable in both groups (Supplemental 
Figure 1). Thus, the difference in arthritis in Nik+/+ and Nik–/– recip-
ients is not due to poor migration or survival of Nik–/– cells.
We next sought to determine whether NIK deficiency in T and/
or B lymphocytes was responsible for the observed resistance to 
AIA. Therefore, we used high-speed flow sorting (MoFlo) to obtain 
pure (>99% by post-sorting analysis; data not shown) populations 
of B and T lymphocytes from both Nik+/+ and Nik–/– spleens, with 
B220 and CD90, respectively, as markers. We then mixed Nik+/+ 
B cells with Nik–/– T cells (5 × 106 of each) or Nik–/– B cells with 
Nik+/+ T cells, prior to injection into Rag2–/– recipients. AIA was 
induced as before. While 0 of 5 recipients of Nik–/– T cells (mixed 
with Nik+/+ B cells) showed histological evidence of arthritis, 3 of 
4 of the recipients of Nik+/+ T cells (mixed with Nik–/– B cells) had 
Table 1
Incidence of arthritis in AIA model
Group	 None	 Mild	 Severe
Nik+/– 0 1 6
Nik–/– 8 1 0
Lt-α–/– 0 1 3
Nik+/+→Rag2–/– 2 1 9
Nik–/–→Rag2–/– 7 1 0
Nik+/+ (B cells) +  5 0 0
  Nik–/– (T cells) → Rag2–/–
Nik–/– (B cells) +  1 0 3
  Nik+/+ (T cells) → Rag2–/–
Rag2–/– 2 0 0
Data indicate the number of mice with a given condition. Arthritis was 
evaluated histologically on H&E-stained sections. The difference 
between Nik+/– and Nik–/– mice and between the Rag2–/– transfer groups 
was significant (P < 0.001). Nik+/+→Rag2–/–, Rag2–/– mice injected with 
Nik+/+ splenocytes; Nik–/–→Rag2–/–, Rag2–/– mice injected with Nik–/– 
splenocytes; Nik+/+ (B cells) + Nik–/– (T cells) → Rag2–/–, Rag2–/– mice 
injected with a mixture of Nik+/+ B cells and Nik–/– T cells; Nik–/– (B cells) 
+ Nik+/+ (T cells) → Rag2–/–, Rag2–/– mice injected with a mixture of 
Nik–/– B cells and Nik+/+ T cells.
Figure 3
Histological evaluation of AIA. (A) PBS-injected control joint, with a rela-
tively acellular joint space (between arrows). (B) mBSA-injected Nik+/– 
knee joint showing a severe inflammatory infiltrate (between arrows) that 
extends beyond the joint capsule, accompanied by bone erosion (corti-
cal thinning; arrowhead). (C) mBSA-injected Nik–/– knee joint resembling 
control joint. (D) mBSA-injected Lt-α–/– joint, showing severe inflamma-
tion despite a lack of lymph nodes. (E) mBSA-injected joint from Rag2–/– 
recipient of Nik+/+ unfractionated splenocytes showing severe arthritis. 
(F) mBSA-injected joint from Rag2–/– recipient of Nik–/– unfractionated 
splenocytes showing no arthritis. (G) mBSA-injected joint from Rag2–/– 
recipient of Nik–/– T cells and Nik+/+ B cells, showing no arthritis. (H) 
mBSA-injected joint from Rag2–/– recipient of Nik+/+ T cells and Nik–/– B 
cells, showing severe arthritis. Magnification in all panels, ×40.
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severe arthritis (Table 1 and Figure 3, G and H). As with unfrac-
tionated splenocytes, the levels of engraftment of WT and NIK-
deficient T cells were comparable, as assessed by flow cytometry 
of spleen at the time of sacrifice (data not shown). Thus, NIK is 
required in T lymphocytes for induction of AIA.
Role of NIK in spontaneous K/BxN arthritis. Having determined 
that NIK is critical in the initiation phase of an acute, antigen-
induced model of arthritis, we next assessed the role of NIK in 
a genetic model of chronic arthritis, the K/BxN model. To this 
end, we separately transferred the NIK-null allele onto the KRN 
T cell receptor–transgenic mouse and onto the H-2g7–transgenic 
mouse. KRN+/ H-2g7 mice of all NIK genotypes were followed with 
paw thickness measurements from 5 weeks of age (Figure 4A). By 
this time, 11 of 13 Nik+/? mice (a group including both Nik+/+	and 
Nik+/– mice) had red, swollen paws, with a total 4-paw thickness 
greater than 10.7 mm. Nik–/– mice (n = 7) had no clinical signs of 
arthritis, and total paw thicknesses ranged from 7.5 to 9.5 mm. By 
the age of 11–15 weeks, all Nik+/– mice (n = 18) had clinical signs of 
arthritis and maximum paw measurements of 11.9 to 15 mm. At 
the time of sacrifice at 11–15 weeks, Nik–/– mice (n = 9) showed no 
clinical arthritis, and none had total paw thickness greater than 
9.6 mm. Histological analysis of both front and hind paws sup-
ports the clinical findings. Nik+/? mice show extensive joint inflam-
mation and extensive bone remodeling, with bone fusions, irreg-
ular shapes, and new bone formation (Figure 4, B and D). Only 
1 of 7 Nik–/– mice examined histologically showed any evidence 
of joint inflammation, with mild arthritis in a single paw. Other 
Nik–/– paws were normal (Figure 4, C and E). We conclude that NIK 
is required for the induction of K/BxN arthritis.
Discussion
NF-κB activation is a component of RA in patients (12), and it 
is also seen in murine models of inflammatory arthritis (14, 15, 
17, 39). Several of these studies have also shown that blockade of 
the classical NF-κB pathway, via inhibition of the IKK complex or 
with IκBα superrepressor (15–17), diminishes the inflammatory 
response and accompanying bone loss. None of these treatments 
is directed at the alternative NF-κB pathway, and possible effects 
of these regimens on the alternative pathway were not addressed. 
Additionally no study has separated an effect on inflammation 
from one on bone erosion when OCs are present. In this article, we 
report that NIK, the primary control point for the activation for 
the alternative NF-κB pathway, is critical for both the immune-
mediated initiation of inflammatory arthritis and for bone erosion 
in the context of a robust neutrophilic inflammatory response.
Our previous studies showed that Nik–/– mice are resistant to the 
osteoclastogenic effects of both exogenous RANKL and PTH in 
vivo (26). The current data derived from the STA model, demon-
strating decreased osteoclastogenesis and bone resorption, extend 
the pathophysiological context of NIK action to include inflam-
matory bone loss. Furthermore, although others have shown that 
inhibition of NF-κB diminishes bone erosion in inflammatory 
arthritis, all of these studies have shown concomitant reductions 
in inflammation (15–17). Although in vitro studies showed direct 
effects on osteoclastogenesis with these inhibitors, the in vivo 
effects might have been primarily mediated via the inflammatory 
component, with the effect on OCs secondary to diminution of the 
inflammation. In contrast, we found that, even in the presence of 
severe inflammation, bone resorption is blocked in the absence of 
NIK. We have shown previously that the loss of NIK activity in the 
OC lineage, but not in lymphocytes, results in defective NF-κB sig-
naling in both the classical and alternative pathways (26). Whether 
this will result in a unique sensitivity of OCs, compared with other 
cell types, to blockade of the NIK pathway must be tested when 
pharmacological inhibitors of this pathway are developed.
Like RA, mBSA-induced AIA results from deposition of immune 
complexes in the affected joints. In order for synovial inflamma-
tion and proliferation and bone erosion to occur, T cells must 
respond to APCs, which leads to B cell production of antibodies 
in the context of a complex array of cytokines including TNF-α, 
IL-1, and IL-6 (4). Both T cell transfer experiments (30, 40) and 
cell depletion experiments (41) demonstrate that CD4+ T cells 
are critical for the initiation of the inflammatory response. The 
complete lack of an inflammatory response in Nik–/– mice sug-
gests an inability of NIK-deficient T cells to respond to mBSA. 
This could be due to intrinsic defects in T cells or APCs or the 
lack of a site for this interaction, i.e., the lack of peripheral lymph 
nodes in Nik–/– mice. Therefore, we assessed the susceptibility to 
AIA of Lt-α–/– mice, which lack lymph nodes but are able to mount 
a high-affinity T cell–dependent antibody response (36, 42) and 
found no difference from wild-type mice. Thus, the presence of 
lymph nodes is not required for the induction of AIA. Neverthe-
less, the lack of lymph nodes in Nik–/– mice might contribute to 
their failure to respond to mBSA challenge, in combination with 
the lymphocyte defects (21, 23, 43). In order to evaluate the capac-
ity of Nik–/– cells to confer susceptibility to AIA in the presence 
Figure 4
Spontaneous K/BxN arthritis. Nik–/– mice and control littermates were 
bred to express both the KRN T cell receptor and H-2g7 allele, a combi-
nation that leads to severe spontaneous arthritis in wild-type mice, appar-
ent by 5 weeks. (A) Total paw thickness (sum of results for all 4 paws) in 
Nik+/? and Nik–/– mice at 5 and 11 weeks of age. *P < 0.0002 compared 
with Nik+/?. (B) Arthritic forepaw from Nik+/+ mouse. (C) Nonarthritic fore-
paw from Nik–/– mouse. (D) Arthritic hind paw from Nik+/+ mouse. (E) Non-
arthritic hind paw from Nik–/– mouse. Magnification, ×40.
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of a normal lymph node stroma, we transferred unfractionated 
splenocytes (containing a mixture of T cells, B cells, and APCs) 
or mixtures of purified T and B cells, into syngeneic Rag2–/– hosts. 
Like SCID mice (40), Rag2–/– mice were resistant to AIA (data not 
shown). Transfer of Nik+/? splenocytes or purified T cells 1 day 
prior to first immunization conferred full susceptibility to AIA, 
while transfer of Nik–/– splenocytes or T cells had no effect, despite 
equivalent engraftment of T cells in the recipient spleens. The lat-
ter is important because of reports that NIK-defective lymphocytes 
show defects in homing to lymphoid organs (38). Thus, the failure 
of Nik–/– mice to respond to AIA is due to T cell dysfunction. Fur-
thermore, although other model systems have shown at least par-
tial immune reactions in NIK-deficient mice (21–23), the complete 
resistance of Nik–/– mice to this arthritis model is unique.
In contrast to the acute serum transfer form of the K/BxN 
model, which can be induced on a wide variety of mouse strains, 
the genetic model, which is spontaneous and chronic, has only 
been evaluated in crosses of KRN transgenic mice with NOD mice 
that express H-2g7. Previously, Mandik-Nayak et al. (44) showed 
that K/BxN mice lacking lymph nodes due to in utero exposure 
to anti–Lt-β receptor antibodies showed a delayed and reduced 
intensity of arthritis, which indicates the importance of lymph 
nodes in this model. However, our experiments, in which we have 
bred Nik–/– mice and control littermates to express KRN and 
H-2g7, represent the first report of additional genetic influences. 
Our findings, based on studies using mice lacking lymph nodes 
but with additional lymphocyte abnormalities, show a more com-
plete inhibition of arthritis, supporting the previous findings and 
suggesting additional contributions of the latter cell types.
The difference in the dependence of the AIA and K/BxN mod-
els on the presence of lymph nodes is interesting. Both models 
depend on systemic antigen-specific T and B lymphocyte respons-
es, although the former is to a foreign antigen, while the latter is 
to a self antigen. Additionally, AIA induction was performed in 
animals with a normal T cell receptor repertoire, while the K/BxN 
model is dependent on the transgenic KRN T cell receptor, which 
is expressed on all T cells.
In summary, our results indicate that NIK is critical for antigen-
mediated induction of arthritis in both AIA and K/BxN models. 
Additionally, NIK controls the pathological induction of osteoclasto-
genesis in the context of the STA model of inflammatory arthritis.
Methods
Animals. Nik–/– mice on the 129Sv/Ev background (18)	were originally pro-
vided by R.D. Schreiber (Washington University, St. Louis, Missouri, USA). 
LT-α–/– and H-2g7 mice were from the Jackson Laboratory. Rag2–/– mice of 
129Sv/Ev background and NOD mice were from Taconic. All mice were 8–12 
weeks of age at the start of experiments for AIA and 6–9 weeks of age for 
serum transfer experiments. The genotype for NIK of all mice used was con-
firmed by PCR analysis of genomic DNA extracted from tail biopsies. Groups 
of mice designated as Nik+/? include a combination of Nik+/+ and Nik+/– mice. 
No quantitative or qualitative differences in the response of Nik+/+ and Nik+/– 
mice were noted. K/BxN serum pools were prepared from arthritic mice 
generated by crossing KRN T cell receptor–transgenic mice with NOD mice 
(29). All experimental protocols were approved by the Institutional Animal 
Studies Committee at Washington University School of Medicine.
AIA. AIA in mice was established as described previously (30). Briefly, mice 
were immunized on days 0 and 7 with 100 µg mBSA (Sigma-Aldrich) emulsi-
fied in 0.1 ml complete Freund’s adjuvant (BD) by intradermal injection at 
the base of tail. At the same time points (i.e., on days 0 and 7) and as an addi-
tional adjuvant, 1 µg pertussis toxin (List Biological Laboratories Inc.) was 
injected intraperitoneally. Arthritis was induced at day 21 by intraarticular 
injection of 100 µg of mBSA in 10 µl sterile PBS into the right knee, while the 
left knee was injected with sterile PBS alone. Mice were sacrificed on day 32.
Cell transfer experiments. For splenocyte transfers, cell suspensions were made 
from pooled spleens, depleted of erythrocytes in red cell removal buffer (154 
mM NH4Cl, 0.1 mM EDTA, 10 mM NaHCO3) for 5 minutes, and adjusted 
to 3 × 108/ml in RPMI media. Splenocytes (3 × 107) were injected into the tail 
vein of nonirradiated Rag2–/– mice 1 day before the mBSA immunization pro-
tocol for AIA described above was started. In this case, 100 ng pertussis toxin 
was used. For experiments using mixtures of B and T lymphocytes, splenocyte 
suspensions from Nik+/+ or Nik–/– mice were stained with APC-conjugated 
B220 and PE-conjugated CD90 (eBioscience Inc.) and sorted using a MoFlo 
high-speed flow cytometer (DakoCytomation). Post-sorting flow cytometry 
showed each population to be more than 99% free of contaminating B or T 
cells. Mixtures of lymphocytes (5 × 106 of each type) were injected by tail vein 
into Rag2–/– recipients, and AIA was induced as for unseparated splenocytes.
Serum transfer model and arthritis scoring. Arthritis was induced by 
intraperitoneal injection of 250 µl K/BxN serum at days 0, 2, and 7 and 50 
µg LPS (E. coli 011:B4; Sigma-Aldrich) on day 2. A clinical index was used to 
evaluate paws over time (1 point for each affected paw; 0.5 points for a paw 
with only mild swelling/redness or only a few digits affected) (34). Ankle 
thickness was measured by dial gauge (Mitutoyo). Both clinical index and 
ankle thickness were assessed in a blinded fashion.
Histological grading of arthritis. Mice were sacrificed, and the hind paws or 
whole knees were dissected and fixed in 10% buffered formalin overnight 
at 4°C. Fixed tissues were decalcified for 10–14 days in 14% EDTA, dehy-
drated, and embedded in paraffin. Sagittal sections (5 µm) were stained 
with H&E or TRAP. Histological sections for the serum transfer model 
were graded blindly. Inflammation and bone erosion were scored on a scale 
of 0 to 3 (0, none; 1, mild; 2, moderate; 3, severe).
Measurement of serum TRAP5b activity. Immediately prior to sacrifice, mice 
were anesthetized and bled retro-orbitally. After clotting and centrifuga-
tion, serum was collected at stored at –80°C prior to analysis using the 
MouseTRAP assay (IDS Inc.) according to the manufacturer’s instructions. 
Samples were tested in duplicate and results compared to the standard 
curve, and mean values expressed as U/l were plotted.
FACS analysis. The spleen cells from transplanted or nontransplanted 
Rag2–/– mice on day 32 were sieved to create single-cell suspensions and 
washed in RPMI media. Erythrocytes were removed from spleen cell sus-
pensions using red cell removal buffer. Cells (1 × 106) were stained with 
FITC-conjugated antibody to CD90 (eBioscience Inc.) and analyzed by 
flow cytometry on a FACScan using CellQuest software (BD).
RNA extraction and semiquantitative RT-PCR. Hind paw ankle joints were iso-
lated from control mice and those at days 3 and 4 of STA, then flash frozen 
in liquid nitrogen and pulverized using a CertiPrep Freezer/Mill 6750 (SPEX 
CertiPrep) under liquid nitrogen to achieve a fine powder of approximate-
ly 2 × 1 × 1 mm. RNA was prepared by extracting the powder with Trizol 
(Invitrogen Corp.), followed by purification with RNeasy (QIAGEN). For 
each data point, tissue from 3 animals was pooled. Generation of cDNA and 
PCR were performed as described previously (26), and the same primers were 
used for GAPDH. Oligonucleotide primer sequences were: RANKL: sense, 
5′-CGTGCAGAAGGAACTGCAACACAT-3′ and antisense, 5′-TGACTTTAT-
GGGAACCCGATGGGA-3′; and TNF-α: sense, 5′-AATGGCCTCCCTCTCAT-
CAGTTCT-3′ and antisense, 5′-TGAGATAGCAAATCGGCTGACGGT-3′. 
All reactions were performed at the same time, with the same amount of 
cDNA, using 24 cycles for GAPDH and 34 cycles for RANKL and TNF-α.
OC culture. OCs were cultured from isolated bone marrow–derived 
macrophages as described previously (26), using recombinant GST-RANKL– 
and M-CSF–containing supernatant. TNF-α was from R&D Systems.
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K/BxN arthritis. Nik+/– mice were crossed with KRN T cell receptor–trans-
genic mice bearing 2 alleles of the transgene. All offspring were screened 
by PCR of tail DNA for NIK genotype and to confirm the presence KRN. 
Separately, Nik+/– mice were crossed with H-2g7–transgenic mice, which 
express H-2Kb. Offspring were screened by PCR for NIK genotype and 
by flow cytometry of peripheral blood for the presence of the H-2g7 allele 
using anti–H-2Kb antibody (BD Biosciences). Nik+/–H-2Ag7+ mice were 
intercrossed, and this second generation was screened for NIK genotype 
by PCR and for H-2Kb levels by flow cytometry. Nik+/– mice expressing the 
highest levels of H-2Kb were considered possible H-2g7 homozygotes, and 
this was tested by mating them to H-2g7-negative mice. If all offspring were 
H-2Kb+ by flow cytometry, then these animals (Nik+/–H-2g7/g7) were used 
for mating with Nik+/–KRN+ genotype mice. All offspring generated by this 
strategy carried H-2g7, approximately half were KRN+, and the NIK geno-
types were normally distributed. Front and hind paw thicknesses of KRN+ 
mice were measured at the ankles by digital gauge.
Statistical analysis. Data are shown as mean ± SD. Group mean values 
were compared by unpaired Student’s t test. For the serum TRAP5b experi-
ment, in which levels were tested before and after induction of arthritis, the 
paired Student’s t test was used.
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